Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Yahoo! Finance
that it will present new Signatera TM data at the San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 10-13 in San Antonio, TX. Natera and its collaborators will present a total of six abstracts. "We are proud to share this new data on Signatera at SABCS that underscores our commitment to generating evidence on the clinical utility of Signatera for patients with breast cancer," said Angel Rodriguez, M.D., senior medical director at Natera. The full list of abstracts with selected highlights are as follows: ZEST Clinical Trial Oral Presentation #GS3-01 | Dec. 13 | Presenter: Nicholas Turner, MD, PhD, FRCP, FMedSci Circulating tumor DNA surveillance in ZEST, a randomized, phase 3, double-blind study of niraparib or placebo in patients with triple-negative breast cancer or HR+ HER2- BRCA-mutated breast cancer with molecular residual disease after definitive therapy ZEST was a randomized, phase III, double-blind trial, sponsored by GSK, that evaluated whether niraparib
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Strong Volume Growth Lifted Natera (NTRA) in Q3 [Yahoo! Finance]Yahoo! Finance
- Clinical Validation Study on Natera's Fetal RhD NIPT Published in Obstetrics & Gynecology [Yahoo! Finance]Yahoo! Finance
- Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & GynecologyBusiness Wire
- Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients [Yahoo! Finance]Yahoo! Finance
- Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant RecipientsBusiness Wire
NTRA
Earnings
- 11/12/24 - Beat
NTRA
Sec Filings
- 12/2/24 - Form 144
- 11/27/24 - Form 4
- 11/26/24 - Form 144
- NTRA's page on the SEC website